ANL - חוב לטווח קצר להון Adlai Nortye Limited

This price chart on GURU.Markets for Adlai Nortye Ltd. (ANL) demonstrates the 0.07 metric. Adlai Nortye Ltd. is a biopharmaceutical firm developing oncology drugs with global sales potential and high margins following patent approval. The company minimizes risks by distributing its research centers across Europe, China, and the US. Supply chain efficiency is ensured through flexible management of regional hubs and precise raw material procurement planning.

For Adlai Nortye Ltd. (ANL), which maneuvers between US and PRC regulators, the structure of short-term liabilities relative to capital serves as an indicator of financial resilience to geopolitical shocks. This metric measures the proportion of loans with a maturity of over one year relative to equity, allowing for an assessment of the business's ability to withstand peak loads and balance excessive caution with the efficient use of borrowed funds.